Canine Protein Losing Enteropathies and Systemic Complications
- PMID: 33131913
- DOI: 10.1016/j.cvsm.2020.09.010
Canine Protein Losing Enteropathies and Systemic Complications
Abstract
Canine protein-losing enteropathies occur commonly in small animal practice, and their management is often challenging with a long-term survival rate of only about 50%. Recent studies have investigated prognostic factors that may determine outcome in individual cases. In particular, systemic complications such as hypercoagulability, vitamin D3 deficiency, and tryptophan deficiency may play an important role and should be investigated in severely affected cases in order to maximize outcome.
Keywords: Hypercoagulability; Lymphangiectasia; PLE; Protein loss; Tryptophan; Vitamin D3.
Published by Elsevier Inc.
Conflict of interest statement
Disclosure K. Allenspach is a cofounder of 3D Health Solutions, Inc., a start-up company developing drug testing assays based on canine organoid technology.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources